Creative Medical Technology Holdings, Inc. (CELZ): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$5.69M
Year ended 2024-12-31
2023-12-31: -$5.56M2024-12-31: -$5.69M-$5.69M
2023-12-31 EBITDA (USD) 2024-12-31
Period endedEBITDAChange YoYSource filing
2024-12-31-$5.69Mn/m2026-03-20, From 2024-01-01
2023-12-31-$5.56Mn/a2025-03-14, From 2023-01-01